Bone Biologics Corporation is a clinical-stage developer of orthobiologic products for spine fusion markets. The Company is focused on bone regeneration in lumbar spinal fusion using neural epidermal growth factor-like 1 protein (NELL-1) in combination with demineralized bone matrix (DBM), a demineralized bone matrix from the Musculoskeletal Transplant Foundation (MTF) Biologics. The combination NELL-1/DBM medical device is an osteopromotive recombinant protein that provides target specific control over bone regeneration. NELL-1 in combination with DBM. NELL-1, a proprietary skeletal-specific growth factor that is a bone void filler. NELL-1 provides regulation over skeletal tissue formation and stem cell differentiation during bone regeneration. The DBM Demineralized Bone Putty provided as part of the convenience kit with NELL-1/DBM is a Class II device. DBM Putty is a matrix composed of processed human cortical bone.
āļŠāļąāļāļĨāļąāļāļĐāļāđāļĒāđāļāļāļāļāļŦāļļāđāļBBLG
āļāļ·āđāļāļāļĢāļīāļĐāļąāļBone Biologics Corp
āļ§āļąāļāļāļĩāđāđāļŠāļāļāļāļēāļĒāļāļĢāļąāđāļāđāļĢāļNov 27, 2015
āļāļĩāļāļĩāđāļFrelick (Jeffrey)
āļāļģāļāļ§āļāļāļāļąāļāļāļēāļ2
āļāļĢāļ°āđāļ āļāļāļēāļĢāļĢāļąāļāļĐāļēāļāļ§āļēāļĄāļāļĨāļāļāļ āļąāļĒOrdinary Share
āļŠāļīāđāļāļāļĩāļāļāļāļĢāļ°āļĄāļēāļNov 27
āļāļĩāđāļāļĒāļđāđ2 Burlington Woods Dr Ste 100
āđāļĄāļ·āļāļBURLINGTON
āļāļĨāļēāļāļŦāļĨāļąāļāļāļĢāļąāļāļĒāđNASDAQ OMX - NASDAQ BASIC
āļāļĢāļ°āđāļāļĻUnited States of America
āļĢāļŦāļąāļŠāđāļāļĢāļĐāļāļĩāļĒāđ01803-4551
āđāļāļĢāļĻāļąāļāļāđ17815524452
āđāļ§āđāļāđāļāļāđhttps://www.bonebiologics.com/
āļŠāļąāļāļĨāļąāļāļĐāļāđāļĒāđāļāļāļāļāļŦāļļāđāļBBLG
āļ§āļąāļāļāļĩāđāđāļŠāļāļāļāļēāļĒāļāļĢāļąāđāļāđāļĢāļNov 27, 2015
āļāļĩāļāļĩāđāļFrelick (Jeffrey)
Mr. Jeffrey Frelick
President, Chief Executive Officer
President, Chief Executive Officer
Mr. Jeffrey Frelick
President, Chief Executive Officer
President, Chief Executive Officer
Ms. Deina H. Walsh, CPA
Chief Financial Officer
Ms. Deina H. Walsh, CPA
Chief Financial Officer
Mr. Bruce Stroever
Independent Chairman of the Board
Independent Chairman of the Board
Dr. Siddhesh Rajendra (Sid) Angle, Ph.D.
Dr. Siddhesh Rajendra (Sid) Angle, Ph.D.
Independent Director
Mr. Robert E. (Rob) Gagnon
Mr. Robert E. (Rob) Gagnon
Independent Director
Mr. Phillip T. Meikle
Independent Director
Mr. Jody Cain
Investor Relation
Mr. Bruce Stroever
Independent Chairman of the Board
Independent Chairman of the Board
āļāļđāđāļāļīāđāļĄāđāļāļīāļĄ
Mr. Jeffrey Frelick
President, Chief Executive Officer
President, Chief Executive Officer
Mr. Jeffrey Frelick
President, Chief Executive Officer
President, Chief Executive Officer
Ms. Deina H. Walsh, CPA
Chief Financial Officer
Ms. Deina H. Walsh, CPA
Chief Financial Officer
Mr. Bruce Stroever
Independent Chairman of the Board
Independent Chairman of the Board
Dr. Siddhesh Rajendra (Sid) Angle, Ph.D.
Dr. Siddhesh Rajendra (Sid) Angle, Ph.D.
Independent Director